Fructose-6-phosphate
Star0
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Fructose-6-phosphate
- DrugBank Accession Number
- DB04493
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 260.1358
Monoisotopic: 260.029718526 - Chemical Formula
- C6H13O9P
- Synonyms
- D-Fructose 6-phosphate
- D-Fructose 6-phosphoric acid
- keto-D-fructose 6-phosphate
- Neuberg ester
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism AFructose-1,6-bisphosphatase 1 inhibitorHumans AFructose-1,6-bisphosphatase isozyme 2 inhibitorHumans U6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 Not Available Humans UATP-dependent 6-phosphofructokinase Not Available Geobacillus stearothermophilus U6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 Not Available Humans UGlucose-6-phosphate isomerase Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as hexose phosphates. These are carbohydrate derivatives containing a hexose substituted by one or more phosphate groups.
- Kingdom
- Organic compounds
- Super Class
- Organic oxygen compounds
- Class
- Organooxygen compounds
- Sub Class
- Carbohydrates and carbohydrate conjugates
- Direct Parent
- Hexose phosphates
- Alternative Parents
- Monosaccharide phosphates / Monoalkyl phosphates / Beta-hydroxy ketones / Acyloins / Alpha-hydroxy ketones / Secondary alcohols / Polyols / Primary alcohols / Organic oxides / Hydrocarbon derivatives
- Substituents
- Acyloin / Alcohol / Aliphatic acyclic compound / Alkyl phosphate / Alpha-hydroxy ketone / Beta-hydroxy ketone / Carbonyl group / Hexose phosphate / Hydrocarbon derivative / Ketone
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- D-fructose 6-phosphate (CHEBI:15946)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2012QM764Y
- CAS number
- 643-13-0
- InChI Key
- GSXOAOHZAIYLCY-HSUXUTPPSA-N
- InChI
- InChI=1S/C6H13O9P/c7-1-3(8)5(10)6(11)4(9)2-15-16(12,13)14/h4-7,9-11H,1-2H2,(H2,12,13,14)/t4-,5-,6-/m1/s1
- IUPAC Name
- {[(2R,3R,4S)-2,3,4,6-tetrahydroxy-5-oxohexyl]oxy}phosphonic acid
- SMILES
- OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O
References
- Synthesis Reference
Kazunori Nishi, Yukiko Hikichi, Yasushi Shintani, "Glutamine: fructose-6-phosphate amidotransferase, its production and use." U.S. Patent US5876713, issued October, 1993.
US5876713- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0000124
- PubChem Compound
- 69507
- PubChem Substance
- 46507447
- ChemSpider
- 62713
- ChEBI
- 15946
- ZINC
- ZINC000085994845
- PDBe Ligand
- F6R
- Wikipedia
- Fructose_6-phosphate
- PDB Entries
- 1fqo / 1x9h / 2bkx / 2gc2 / 2put / 2v4m / 3opq / 3s1v / 3t2e / 3te9 … show 17 more
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 23.2 mg/mL ALOGPS logP -1.9 ALOGPS logP -3.4 Chemaxon logS -1 ALOGPS pKa (Strongest Acidic) 1.49 Chemaxon pKa (Strongest Basic) -3.3 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 8 Chemaxon Hydrogen Donor Count 6 Chemaxon Polar Surface Area 164.75 Å2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 48.43 m3·mol-1 Chemaxon Polarizability 20.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption - 0.9611 Blood Brain Barrier + 0.8427 Caco-2 permeable - 0.719 P-glycoprotein substrate Non-substrate 0.6769 P-glycoprotein inhibitor I Non-inhibitor 0.7754 P-glycoprotein inhibitor II Non-inhibitor 0.9852 Renal organic cation transporter Non-inhibitor 0.9036 CYP450 2C9 substrate Non-substrate 0.8058 CYP450 2D6 substrate Non-substrate 0.8213 CYP450 3A4 substrate Non-substrate 0.598 CYP450 1A2 substrate Non-inhibitor 0.8775 CYP450 2C9 inhibitor Non-inhibitor 0.8872 CYP450 2D6 inhibitor Non-inhibitor 0.9132 CYP450 2C19 inhibitor Non-inhibitor 0.8535 CYP450 3A4 inhibitor Non-inhibitor 0.9779 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9722 Ames test Non AMES toxic 0.8428 Carcinogenicity Non-carcinogens 0.8882 Biodegradation Ready biodegradable 0.5929 Rat acute toxicity 2.0213 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8777 hERG inhibition (predictor II) Non-inhibitor 0.8459
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 158.5046446 predictedDarkChem Lite v0.1.0 [M-H]- 159.8474446 predictedDarkChem Lite v0.1.0 [M-H]- 153.3365446 predictedDarkChem Lite v0.1.0 [M-H]- 148.27754 predictedDeepCCS 1.0 (2019) [M+H]+ 155.7320446 predictedDarkChem Lite v0.1.0 [M+H]+ 159.0554446 predictedDarkChem Lite v0.1.0 [M+H]+ 155.9705446 predictedDarkChem Lite v0.1.0 [M+H]+ 150.67311 predictedDeepCCS 1.0 (2019) [M+Na]+ 155.6668446 predictedDarkChem Lite v0.1.0 [M+Na]+ 156.9197446 predictedDarkChem Lite v0.1.0 [M+Na]+ 154.9295446 predictedDarkChem Lite v0.1.0 [M+Na]+ 156.61427 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsFructose-1,6-bisphosphatase 1
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Yes
- Actions
- Inhibitor
- General Function
- Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations, acting as a rate-limiting enzyme in gluconeogenesis. Plays a role in regulating glucose sensing and insulin secretion of pancreatic beta-cells. Appears to modulate glycerol gluconeogenesis in liver. Important regulator of appetite and adiposity; increased expression of the protein in liver after nutrient excess increases circulating satiety hormones and reduces appetite-stimulating neuropeptides and thus seems to provide a feedback mechanism to limit weight gain
- Specific Function
- AMP binding
- Gene Name
- FBP1
- Uniprot ID
- P09467
- Uniprot Name
- Fructose-1,6-bisphosphatase 1
- Molecular Weight
- 36842.145 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
- Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751. [Article]
2. DetailsFructose-1,6-bisphosphatase isozyme 2
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Yes
- Actions
- Inhibitor
- General Function
- Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations and probably participates in glycogen synthesis from carbohydrate precursors, such as lactate
- Specific Function
- fructose 1,6-bisphosphate 1-phosphatase activity
- Gene Name
- FBP2
- Uniprot ID
- O00757
- Uniprot Name
- Fructose-1,6-bisphosphatase isozyme 2
- Molecular Weight
- 36742.84 Da
References
- Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Synthesis and degradation of fructose 2,6-bisphosphate
- Specific Function
- 6-phosphofructo-2-kinase activity
- Gene Name
- PFKFB1
- Uniprot ID
- P16118
- Uniprot Name
- 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1
- Molecular Weight
- 54680.86 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
4. DetailsATP-dependent 6-phosphofructokinase
- Kind
- Protein
- Organism
- Geobacillus stearothermophilus
- Pharmacological action
- Unknown
- General Function
- Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis.
- Specific Function
- 6-phosphofructokinase activity
- Gene Name
- pfkA
- Uniprot ID
- P00512
- Uniprot Name
- ATP-dependent 6-phosphofructokinase
- Molecular Weight
- 34118.62 Da
References
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Synthesis and degradation of fructose 2,6-bisphosphate
- Specific Function
- 6-phosphofructo-2-kinase activity
- Gene Name
- PFKFB4
- Uniprot ID
- Q16877
- Uniprot Name
- 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4
- Molecular Weight
- 54039.34 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
6. DetailsGlucose-6-phosphate isomerase
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- In the cytoplasm, catalyzes the conversion of glucose-6-phosphate to fructose-6-phosphate, the second step in glycolysis, and the reverse reaction during gluconeogenesis (PubMed:28803808). Besides it's role as a glycolytic enzyme, also acts as a secreted cytokine: acts as an angiogenic factor (AMF) that stimulates endothelial cell motility (PubMed:11437381). Acts as a neurotrophic factor, neuroleukin, for spinal and sensory neurons (PubMed:11004567, PubMed:3352745). It is secreted by lectin-stimulated T-cells and induces immunoglobulin secretion (PubMed:11004567, PubMed:3352745)
- Specific Function
- carbohydrate derivative binding
- Gene Name
- GPI
- Uniprot ID
- P06744
- Uniprot Name
- Glucose-6-phosphate isomerase
- Molecular Weight
- 63146.745 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at June 13, 2005 13:24 / Updated at October 03, 2024 04:24